14 completed. 14 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 14 |
| Phase 2 | 3 | Completed 3 |
Follow Anorexia: new trials by email Literature Review of Anorexia trials Research Report on Anorexia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia Itopride Hydrochloride 150 mg extended release tablets, Itopride Hydrochloride 50 mg film coated tablets - Functional Dyspepsia | Phase 3 | Completed | Abbott | 564 | 2024-02-28 | 2026-04-03 |
| Effectiveness of Cannabinoids on Appetite in Scleroderma CBD oil, Placebo - Systemic Sclerosis, Malnutrition | Phase 3 | Completed | Khon Kaen University | 30 | 2022-11-09 | 2025-02-20 |
| Olanzapine Anorexia Cachexia Olanzapine 5 MG, Placebo - Anorexia | Phase 3 | Completed | Cairo University | 164 | 2021-12-25 | 2024-10-03 |
| A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression Trazodone, Placebo - Depression | Phase 2 / Phase 3 | Completed | Lee's Pharmaceutical Limited | 382 | 2011-11-01 | 2014-10-16 |
| Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS) Olanzapine - Amyotrophic Lateral Sclerosis (ALS) | Phase 2 / Phase 3 | Completed | Charite University, Berlin, Germany | 40 | 2011-03-01 | 2024-02-14 |
| Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder Low Dose Fish Oil, High Dose Fish Oil - Major Depressive Disorder | Phase 2 / Phase 3 | Completed | University of Cincinnati | 20 | 2007-08-01 | 2016-05-27 |
| Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients Melatonin, Placebo - Gastrointestinal Cancer, Lung Cancer | Phase 3 | Completed | M.D. Anderson Cancer Center | 82 | 2006-06-01 | 2012-12-11 |
| Creatine in Treating Patients With Cancer-Associated Weight Loss creatine monohydrate, placebo - Anorexia, Cachexia | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 300 | 2004-12-01 | 2020-04-29 |
| Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer etanercept - Anorexia, Cachexia | Phase 3 | Completed | Mayo Clinic | 2003-05-01 | 2011-05-05 | |
| Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) infliximab, docetaxel, placebo - Anorexia, Cachexia | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 67 | 2002-10-01 | 2016-12-07 |
| Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer megestrol acetate, quality-of-life assessment - Anorexia, Cachexia | Phase 3 | Completed | Wake Forest University Health Sciences | 13 | 2000-10-01 | 2021-09-09 |
| Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer megestrol acetate, radiation therapy - Anorexia, Cachexia | Phase 3 | Completed | Wake Forest University Health Sciences | 25 | 2000-09-01 | 2021-09-09 |
| Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite eicosapentaenoic acid, megestrol acetate, placebo - Anorexia, Cachexia | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 429 | 2000-03-01 | 2016-07-14 |
| A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia Megestrol acetate - Anorexia, Cachexia | Phase 3 | Completed | Bristol-Myers Squibb | 2007-10-02 |
Cachexia (9) · Lung Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (2) · Fatigue (2) · Malnutrition (2) · Abdominal Pain (1) · Acquired Immunodeficiency Syndrome (1) · Amyotrophic Lateral Sclerosis (1) · Body Weight (1) · Body Weight Changes (1) · Depression (1) · Depressive Disorder, Major (1) · Esthesioneuroblastoma, Olfactory (1) · Gastrointestinal Neoplasms (1)
Pathological Conditions, Signs and Symptoms (14) · Signs and Symptoms (14) · Signs and Symptoms, Digestive (14) · Thinness (9) · Body Weight (8) · Body Weight Changes (8) · Weight Loss (8) · Neoplasms (4) · Neoplasms by Site (4) · Lung Diseases (3) · Nervous System Diseases (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Thoracic Neoplasms (3) · Bronchial Neoplasms (2)
Megestrol Acetate (4) · Olanzapine (2) · Creatine (1) · Docetaxel (1) · Eicosapentaenoic Acid (1) · Etanercept (1) · Fish Oils (1) · Infliximab (1) · Melatonin (1) · Radiotherapy (1) · Trazodone (1)
Alliance for Clinical Trials in Oncology (3) · Wake Forest University Health Sciences (2) · Abbott (1) · Bristol-Myers Squibb (1) · Cairo University (1) · Charite University, Berlin, Germany (1) · Khon Kaen University (1) · Lee's Pharmaceutical Limited (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · University of Cincinnati (1)
United States (9) · Thailand (2) · Armenia (1) · Canada (1) · China (1) · Egypt (1) · Germany (1) · Malaysia (1) · Philippines (1) · Vietnam (1)
Aminah Jatoi, MD (4) · Benjamin LI, Ph.D. (1) · Chingching Foocharoen, M.D. (1) · Edward G. Shaw, MD (1) · Kathryn M. Greven, MD (1) · Robert McNamara, PhD (1) · Rony Dev, DO (1) · S Al Sirafy, Professor (1) · Suntje Sander (1) · Thomas Meyer, MD (1)
PMID 15197210, PMID 17674351, PMID 19665818, PMID 23439759, PMID 41137182